In several Russian regions
a vital drug is missing from pharmacies, which is used at the risk of thrombosis. Usually it was prescribed to pregnant women, but now it is necessary for those with coronavirus. This was told by RBC with reference to a study by DSM Group analysts.
We are talking about an injection solution based on sodium enoxaparin, which contains drugs such as Anfibra, Gemapaksan, Kleksan, Kleniks, Flenkos neo. Its deficit is reported by residents of Moscow, the Moscow region, the Sverdlovsk and Yaroslavl regions, the Republic of Mari El, Tyumen and Novosibirsk.
Yuri Mochalin, director of corporate relations at the Sanofi pharmaceutical company, which produces Clexane, told the publication that the lack of the drug was caused by a pandemic and rush demand. But according to Sergey Shulyak, general director of DSM Group, the reason lies in problems with labeling - because of this, sometimes even the drug that has entered the warehouse cannot be sold.
On the eve of Plus-one.ru said that due to failures in the drug labeling system in Russia, 40 million packages were "stuck". Approximately 450 names of drugs cannot reach the patients.]]>